The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways.

MAY 17, 2019

DALLAS, TX

Past

SPEAKERS

Cecelia Gonzalo

Cecilia Gonzalo

Partner
Oberland Capital

Colin Reisner

Colin Reisner, MD

CEO/Head, Respiratory Global Medicines
Pearl Therapeutics/AstraZeneca

Chau-Q-Khuong

Chau Khuong

Private Equity Partner
OrbiMed

Mahendra Shah

Mahendra Shah, PhD

Managing Director
Vivo Capital

Irina Petrache

Irina Petrache, MD

Chief & Professor, Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health

Linda Armstrong

Linda Armstrong, MD

Global Head Respiratory Development Unit
Novartis

Gregory Grunberg

Gregory Grunberg, MD

Managing Director
Longitude Capital

Onaiza-Cadoret

Onaiza Cadoret Manier

VP, Respiratory Franchise
Genentech

Charles

Charles Hamilton

Principal, Investment Banking Healthcare
Piper Jaffray

Matthew McMahon

Matthew McMahon, PhD

Director, Office of Translational Alliances & Coordination
National Heart, Lung & Blood Institute, NIH

FDA

Sally Seymour, MD

Division Director (Acting) Division of Pulmonary, Allergy, & Rheumatology Products Center for Drug Evaluation & Research
US Food & Drug Administration (FDA)

James Willett

EVP, Chief Product & Innovation Officer
Vyaire

Ted Omachi

Ted Omachi, MD

Medical Director
Genentech

Theodore Reiss

Theodore Reiss, MD, MBE

Corporate VP, Head of I&I Clinical R&D
Celgene Corporation

Badrul Chowdhury

Badrul Chowdhury, MD, PhD

SVP & Head of the Respiratory, Inflammation & Autoimmunity (RIA) Innovative Medicines Unit
MedImmune (AstraZeneca)

Anthony Flores

Anthony Flores

Managing Director, Head of Southwest Life Sciences & Healthcare
Silicon Valley Bank

Jason Chien

Jason Chien, MD

Senior Director, Clinical Research: Inflammation & Respiratory Division
Gilead Sciences

Ben Kramer

Benjamin Kramer, MD

VP, Immunology & Ophthalmology, US Medical Affairs
Genentech

Glenn French

Glen French

CEO
Pulmonx Corporation

Tim Watkins

Timothy Watkins, MD

Director of Clinical Research, Respiratory & Inflammation Therapeutics
Gilead Sciences

James Rosen

James Rosen

Managing Partner
Three Lakes Partners

Tara Butler

Tara Butler, MD

Managing Director
Ascension Ventures

Tom Salemi

Tom Salemi

Content Director
Healthegy

Kevin Kinsella

Kevin Kinsella

Founding Partner
Avalon Ventures

Marc Moss

Marc Moss, MD

President
American Thoracic Society

Dennis Wahr

Dennis Wahr, MD

President & CEO
Nuvaira

Fred Van Goor

Fred Van Goor, PhD

Principal Research Fellow
Vertex Pharmaceuticals

Bill Gerhart

Bill Gerhart

Chairman & CEO
Patara Pharma

Highlights

FROM THE FIRST RIS@ATS

Meet Our

CO-CHAIRS

Oberland Capital

Gilead Sciences Inc.

1e6a446

RIS Co-Chair Tim Watkins, MD

Director of Clinical Research, Respiratory & Inflammation Therapeutics / Gilead Sciences Inc.

“We’re in an exciting time right now scientifically. It’s critical to put great minds together in the same place to talk about new technologies, new devices, new therapeutics that are in development. We need to capitalize on that cooperation so we move the needle more quickly and get new therapeutics to patients who desperately need them.”

Cecilia Gonzalo

RIS Co-Chair Cecilia Gonzalo

Managing Director / Vatera Holdings, LLC

“I have been an investor in various respiratory companies over the years and believe that the respiratory space continues to be an area with significant unmet needs. With an aging demographic and growing populations around the world, the number of patients impacted by respiratory diseases only continues to increase, and I believe in the importance of continuing to innovate in this space.”

Topics & Themes

THAT MATTER

Turning Innovative Ideas into Products

Bridging the Gap Between Academia and Industry

Peering into the Pipeline of Industry’s Life-saving Treatments

Finding the Right Financing to Advance Your Pipeline

Hearing from the Entrepreneurs Leading Promising Start-Ups

Audience That Stays

AHEAD OF THE CURVE

Attendees are senior level decision makers, innovating physicians and industry leaders with direct impact in respiratory

INVESTORS

Angels


Family Funds


Government


Venture Capitalists


Financial Institutions


Corporate/Strategic

INDUSTRY LEADERS

C-Suite


Presidents


Division Heads


Business Development


Heads of R&D

INNOVATORS

Entrepreneurs


Researchers


Start-ups


Physicians


Patients

KEY OPINION LEADERS

Pulmonologists


Critical
Care Providers


Allergists


Cardiologists

Affiliate

LOCATION

American Thoracic Society

May 17 - May 22, Dallas, TX

GET INVOLVED

Interested in taking a leadership or active role? There are several ways to get involved.